The estimated Net Worth of Lynn Rothman is at least 22.7 百万$ dollars as of 1 October 2021. Ms. Rothman owns over 5,300 units of Penumbra Inc stock worth over 7,675,034$ and over the last 9 years she sold PEN stock worth over 14,409,169$. In addition, she makes 605,128$ as Executive Vice President、 Chief Business Officer at Penumbra Inc.
Sign up
Ms. Rothman PEN stock SEC Form 4 insiders trading
Lynn has made over 40 trades of the Penumbra Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 5,300 units of PEN stock worth 116,812$ on 1 October 2021.
The largest trade she's ever made was exercising 10,155 units of Penumbra Inc stock on 7 May 2021 worth over 40,417$. On average, Lynn trades about 4,702 units every 41 days since 2015. As of 1 October 2021 she still owns at least 37,937 units of Penumbra Inc stock.
You can see the complete history of Ms. Rothman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Lynn Rothman biography
Lynn D. Rothman serves as Executive Vice President, Chief Business Officer of the Company. She joined Penumbra in 2007. She has served as Executive Vice President and Chief Business Officer since January 2015; as Chief Financial Officer from March 2009 to January 2015; as Vice President, Administration from January 2009 to March 2009, and as Human Resources Manager from 2007 to January 2009. Ms. Rothman joined Penumbra with over 20 years of experience in finance and marketing of medical and emerging growth companies. Ms. Rothman served as Director of Corporate Marketing at Confer Software, Inc., a disease management company, from 1997 to 2000. Prior to that time, Ms. Rothman worked at Robertson, Stephens & Company, a financial services firm, where she worked in both health care research and venture capital focused on potential medical device, service and software investment opportunities.
What is the salary of Lynn Rothman?
As the Executive Vice President、 Chief Business Officer of Penumbra Inc, the total compensation of Lynn Rothman at Penumbra Inc is 605,128$. There are 3 executives at Penumbra Inc getting paid more, with Johanna Roberts having the highest compensation of 2,556,370$.
How old is Lynn Rothman?
Lynn Rothman is 59, she's been the Executive Vice President、 Chief Business Officer of Penumbra Inc since 2015. There are 1 older and 14 younger executives at Penumbra Inc. The oldest executive at Penumbra Inc is Don Kassing, 78, who is the Presiding Independent Director.
What's Lynn Rothman's mailing address?
Lynn's mailing address filed with the SEC is ONE PENUMBRA PLACE, , ALAMEDA, CA, 94502.
Insiders trading at Penumbra Inc
Over the last 9 years, insiders at Penumbra Inc have traded over 197,637,326$ worth of Penumbra Inc stock and bought 700 units worth 109,480$ . The most active insiders traders include Adam Elsesser、Arani Bose、James Robert Pray. On average, Penumbra Inc executives and independent directors trade stock every 9 days with the average trade being worth of 2,030,383$. The most recent stock trade was executed by Harpreet Grewal on 4 September 2024, trading 782 units of PEN stock currently worth 159,614$.
What does Penumbra Inc do?
penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
What does Penumbra Inc's logo look like?
Complete history of Ms. Rothman stock trades at Penumbra Inc
Penumbra Inc executives and stock owners
Penumbra Inc executives and other stock owners filed with the SEC include:
-
Johanna Roberts,
Executive Vice President, General Counsel, Secretary -
Maggie Yuen,
Chief Financial Officer -
Adam Elsesser,
Chairman of the Board, Chief Executive Officer -
Lynn Rothman,
Executive Vice President, Chief Business Officer -
Maggie S. Yuen,
Chief Financial Officer -
James Pray,
President, International -
Arani Bose,
Chief Innovator, Director -
Johanna Roberts,
Exec. VP, Gen. Counsel & Sec. -
Lambert Shiu,
Chief Accounting Officer -
Janet Leeds,
Independent Director -
Surbhi Sarna,
Independent Director -
Adam Elsesser,
Co-Founder, Chairman, Pres & CEO -
Harpreet Grewal,
Independent Director -
Bridget O'Rourke,
Independent Director -
Thomas Wilder,
Independent Director -
Don Kassing,
Presiding Independent Director -
Lambert Shiu,
Chief Accounting Officer -
Gita Barry,
Exec. VP & GM of Immersive Healthcare -
Ben Tompkins,
Exec. VP of Devel. -
Shruthi Narayan,
Director of Marketing - Vascular -
Dr. Arani Bose M.D.,
Co-Founder & Director -
Jee Hamlyn-Harris,
Investor Relations Officer -
Corey L. Teigen M.D.,
Chief Scientific Officer -
Ben Sorci,
Exec. VP of Operations -
Kevin James Sullivan,
Director -
Robert D. Evans,
EVP, Gen. Counsel & Secretary -
Daniel Donen Davis,
President, North America -
Sridhar Kosaraju,
President -
Walter Charles Wang,
Director